Potentially inappropriate medication use in a comprehensive therapy management service: clinical outcomes and interventions

• Main Author: Martins, Ursula Carolina de Morais
• Publication Date: 2022
• Other Authors: Ramalho de Oliveira, Djenane, Nascimento, Mariana Martins Gonzaga do, Nascimento, Yone de Almeida, Oliveira, Grazielli Cristina Batista de, Cid, Annaline Stiegert, Lima, Marina Guimarães
• Format: Article
• Language: eng
• Source: Brazilian Journal of Pharmaceutical Sciences
• Download full: https://www.revistas.usp.br/bjps/article/view/205059
• topic: Brazil; Aged; Medication therapy management; Potentially inappropriate medication list; Pharmaceutical care

This study aimed to describe potentially inappropriate medication (PIM) use according to the Beers criteria among older adults followed in a comprehensive medication management (CMM) service, the pharmacists´ interventions, and the clinical outcomes of PIM use. All older adults in a CMM service delivered in the Brazilian public primary care system were included in the study (n = 389). Two methodological approaches were developed: (I) cross-sectional - prevalence of PIM use and associated factors were identified (univariate analysis - Pearson’s chi-square; multivariate - logistic regression); (II) documental analysis of the negative clinical outcomes potentially associated with PIM use and pharmacists’ interventions. The prevalence of PIM use was 48.3%, and it was independently and positively associated with the use of ≥ 5 drugs. For 21.3% of PIMs, a potential negative clinical outcome was identified. The most common negative clinical outcome was hypotension (35.1% of the negative outcomes), fractures or diagnosis of osteoporosis (21.1%), and hypoglycemia (14.0%). For most of them (78.9%), an intervention was performed to mitigate harm or discontinue use. A high prevalence of PIM was detected and was associated with polypharmacy. A significant proportion of PIM showed potential negative clinical outcomes that were identified by clinical pharmacists, and the majority of pharmacists’ interventions aimed at its mitigation or deprescription. Overall, our findings reinforce the potential of CMM services for reducing PIM use and the occurrence of negative outcomes.